Publications and Conference Presentations

  1. Roufogalis BD, Duke CC, Li Q (1998): Use of natural products and related synthetic compounds for the treatment of cardiovascular diseases. United States Patent, Patent Number 5741821, April 21, 1998.
  2. Roufogalis BD, Li Q, Tran VH, Kable, EPW, and Duke CC (1999). Investigation of plant derived phenolic compounds as plasma membrane Ca2+-ATPase inhibitors with potential cardiovascular activity. Drug Development Research. 3-4, 235-249.
  3. Dedov, V.N. and Roufogalis, B.D. (2000) Mitochondrial calcium accumulation following activation of vanilloid (VR1) receptors by capsaicin in dorsal root ganglion neurons. Neuroscience 95, 183-188.
  4. Chrubasik, S. and Roufogalis, B.D. (2000) Eds. Herbal Medicinal Products for the Treatment of Pain. Southern Cross University Press, Lismore, Australia.
  5. Roufogalis, B. and Dedov, V. (2000) Capsaicin Receptor Mechanism and Future Trends for Analgesics. In: Chrubasik, S. and Roufogalis, B.D. Herbal Medicinal Products for the Treatment of Pain. Southern Cross University Press, Lismore, Australia, pp 94-99.
  6. Duke CC, Goh PP, McLachlan AJ, Roufogalis BD. Essential CPE: Complementary Medicines. Ed: Fitzsimons M; Pharmaceutical Society of Australia, May, 2001, National Capital Printing, ACT.
  7. Tjendraputra, E., Tran, V.H., Liu-Brennan, D., Roufogalis, B.D. and Duke, C.C. (2001) Effects of ginger constituents and synthetic analogues on cyclooxygenase-2 (COX-2) enzyme in intact cells. Bioorganic Chemistry 29, 156-163.
  8. Koo, K.L.K., Ammit, A.J., Tran, V.H., Duke, C.C. and Roufogalis, B.D. (2001) Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thrombosis Research. 103, 387-397.
  9. Chrubasik S and Roufogalis BD (2002). Phytomedicines for respiratory tract diseases. Australian Pharmaceutical Publishing Company Ltd: Balmain, Australia
  10. Dedov, V.D, Tran, V.H., Duke, C.C., Connor, M., Christie, M.J., Mandadi, S. and Roufogalis, B.D. (2002) Gingerols: a novel class of vanilloid receptor (VR1) agonists. British Journal of Pharmacology 137 (6):793-8.
  11. Li Q, Duke CC, Roufogalis BD. The Progress of Chinese Medicine in Australia, chapter in The Way Forward for Chinese Medicine, P 173 to 190. Kelvin Chan and Henry Lee, 2002, Taylor & Francis.
  12. George Q Li, Colin C Duke, and Basil D Roufogalis (2003). The Quality and Safety of Traditional Chinese Medicines, Australian Prescriber Vol 26 No6, p128-130.
  13. Coxeter, P.D., McLachlan, A.J., Duke, C.C. and Roufogalis, B.D. (2003) Interaction or over-reaction? Journal of Complementary Medicine 2(1), 60-61.
  14. Coxeter, P.D., McLachlan, A.J., Duke, C.C. and Roufogalis, B.D. (2003) St John's wort interactions. Journal of Complementary Medicine 2(2), 66-68.
  15. Coxeter, P.D., McLachlan, A.J., Duke, C.C. and Roufogalis BD. (2003) Ginkgo biloba interactions. Journal of Complementary Medicine 2(3), 62-64.
  16. Coxeter, P.D., McLachlan, A.J., Duke, C.C. and Roufogalis, B.D. (2003) Ginseng interactions. The Journal of Complementary Medicine 2(5):54-56.
  17. Coxeter, P.D., McLachlan, A.J., Duke, C.C. and Roufogalis, B.D. (2003) Liquorice interactions. The Journal of Complementary Medicine 2(4):40-42.
  18. Yuhao Li, Gang Peng, Qian Li, Suping Wen, Tom Hsun-Wei Huang, Basil D Roufogalis, Johji Yamahara (2004). Salacia oblonga Improves Cardiac Fibrosis and Inhibits Postprandial Hyperglycemia in Obese Zucker Rats. Life Sciences; 75:1735-1746.
  19. Coxeter PD, McLachlan AJ, Duke CC, and Roufogalis BD (2004). Herb-Drug Interaction: An Evidence Based Approach. Current Medicinal Chemistry. 11, 1513-1525
  20. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ (2004). Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology; 57(5):592-9.
  21. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ (2005). Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 59 (4): 425-432
  22. Huang, Tom HW, Gang Peng, Bhavani P Kota, George Q Li, Johji Yamahara, Basil D Roufogalis, Yuhao Li. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. Br J Pharmacol. 2005 May 9; [Epub ahead of print] p1-8.
  23. Li, Yuhao, Suping Wen, Bhavani Prasad Kota, Gang Peng, George Qian Li, Johji Yamahara, Basil D Roufogalis. Punica granatum flower extract, a potent α-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. J Ethnopharmacol. 2005; 99(2): 239-244.
  24. Huang, Tom HW, Gang Peng, Bhavani P Kota, George Q Li, Johji Yamahara, Basil D Roufogalis, Yuhao Li. Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component. Toxicol Appl Pharmacol. Accepted for publication.
  25. Huang, Tom Hsun-Wei, Gang Peng, George Qian Li, Johji Yamahara, Basil D Roufogalis, Yuhao Li, Salacia oblonga root, a novel PPAR-α activator, improves postprandial hyperlipidemia and excess cardiac triglyceride accumulation in Zucker diabetic fatty rats, Toxicology and Applied Pharmacology, 2005; Jun 20; [Epub ahead of print]